{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:51:36Z","timestamp":1786121496597,"version":"build-2736575974"},"reference-count":130,"publisher":"Informa UK Limited","issue":"sup1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"National Bleeding Disorders Foundation"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.1080\/17474086.2026.2688870","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:59:07Z","timestamp":1786078747000},"page":"23-42","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Lived Experience Expert, community engagement, policy, and health equity, diversity, and inclusion elements of the Bleeding Disorders Research Collaborative"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-5709","authenticated-orcid":false,"given":"Kyle A.","family":"Davis","sequence":"first","affiliation":[{"name":"Lived Experience Expert","place":["Columbus, USA"]},{"name":"Innovative Hematology, Inc","place":["Indianapolis, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3519-3502","authenticated-orcid":false,"given":"Nathan","family":"Mermilliod","sequence":"additional","affiliation":[{"name":"Lived Experience Expert, National Bleeding Disorders Foundation National Youth Leadership Institute","place":["Riverside, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Griffin","sequence":"additional","affiliation":[{"name":"New York City Hemophilia Chapter","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3148-7324","authenticated-orcid":false,"given":"Samantha A.","family":"Carlson","sequence":"additional","affiliation":[{"name":"National Bleeding Disorders Foundation","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Burke Cirelli","sequence":"additional","affiliation":[{"name":"Lived Experience Expert, New York City Hemophilia Chapter","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Conde","sequence":"additional","affiliation":[{"name":"Hemophilia of Georgia","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6208-4682","authenticated-orcid":false,"given":"Donna","family":"DiMichele","sequence":"additional","affiliation":[{"name":"Donna DiMichele Consulting, LLC","place":["USA"]},{"name":"Weill Cornell Medical College","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2560-310X","authenticated-orcid":false,"given":"Alexis","family":"Dinno","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University-Portland State University School of Public Health","place":["Portland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7089-5813","authenticated-orcid":false,"given":"Michael","family":"Glenzer","sequence":"additional","affiliation":[{"name":"Lived Experience Expert","place":["San Diego, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9372-3184","authenticated-orcid":false,"given":"Roshni","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Michigan State University","place":["East Lansing, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Legere","sequence":"additional","affiliation":[{"name":"New York City Hemophilia Chapter","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5311-5282","authenticated-orcid":false,"given":"Marissa","family":"Melton","sequence":"additional","affiliation":[{"name":"National Bleeding Disorders Foundation","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-2779","authenticated-orcid":false,"given":"Keri L.","family":"Norris","sequence":"additional","affiliation":[{"name":"National Bleeding Disorders Foundation","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pezzillo","sequence":"additional","affiliation":[{"name":"Lived Experience Expert, New England Hemophilia Association","place":["Dedham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2805-1016","authenticated-orcid":false,"given":"Michael","family":"Recht","sequence":"additional","affiliation":[{"name":"National Bleeding Disorders Foundation","place":["New York, USA"]},{"name":"Yale School of Medicine","place":["New Haven, USA"]},{"name":"Pathway to Cures","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-271X","authenticated-orcid":false,"given":"Fiona","family":"Robinson","sequence":"additional","affiliation":[{"name":"Communications Fiona Robinson, PhD","place":["Montr\u00e9al, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-677X","authenticated-orcid":false,"given":"Maria E.","family":"Santaella","sequence":"additional","affiliation":[{"name":"National Bleeding Disorders Foundation","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1784-6566","authenticated-orcid":false,"given":"Nathan","family":"Schaefer","sequence":"additional","affiliation":[{"name":"National Bleeding Disorders Foundation","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9259-054X","authenticated-orcid":false,"given":"Raymond W.","family":"Stanhope","sequence":"additional","affiliation":[{"name":"Lived Experience Expert, Lone Star Bleeding Disorders Foundation","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3485-8470","authenticated-orcid":false,"given":"Sammie","family":"Valadez","sequence":"additional","affiliation":[{"name":"Lived Experience Expert, Bleeding Disorders Alliance of Illinois","place":["Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-6418","authenticated-orcid":false,"given":"Leonard A.","family":"Valentino","sequence":"additional","affiliation":[{"name":"National Bleeding Disorders Foundation","place":["New York, USA"]},{"name":"Rush University","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"V\u00e1zquez","sequence":"additional","affiliation":[{"name":"Lived Experience Expert","place":["Chicago, USA"]},{"name":"Genentech","place":["South San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-1854","authenticated-orcid":false,"given":"Mosi","family":"Williams","sequence":"additional","affiliation":[{"name":"Lived Experience Expert","place":["San Francisco, USA"]},{"name":"Sporty Strategies","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0758-286X","authenticated-orcid":false,"given":"Michelle","family":"Witkop","sequence":"additional","affiliation":[{"name":"Consultant for Inherited Bleeding Disorders","place":["Traverse City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0644-1689","authenticated-orcid":false,"given":"Shannon L.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Children\u2019s Mercy Hospital","place":["Kansas City, USA"]},{"name":"University of Missouri-Kansas City","place":["Kansas City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.11.011"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.19.1.173"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bvth.2025.100099"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2175660"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2175661"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2171983"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2171981"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2183836"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2181781"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2181782"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2023.2178410"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2026.2688871"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2026.2688873"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13862"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067659"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01946.x"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001311"},{"key":"e_1_3_6_19_1","unstructured":"National Bleeding Disorders Foundation. Improving outcomes for Women Girls and people who have or had the potential to menstruate (WGPPM): a roadmap for moving forward Available from: https:\/\/www.bleeding.org\/sites\/default\/files\/document\/files\/WGPPM-Summit-White-Paper.pdf"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14956"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012862"},{"key":"e_1_3_6_22_1","unstructured":"U.S. Food and Drug Administration. Prescribing Information. ROCTAVIAN (valoctocogene roxaparvovec-rvox) suspension for intravenous infusion Available from: https:\/\/www.fda.gov\/media\/169937\/download?attachment"},{"key":"e_1_3_6_23_1","unstructured":"U.S. Food and Drug Administration. Prescribing Information. HEMGENIX (etranacogene dezaparvovec-drlb) suspension for intravenous infusion. Available from: https:\/\/www.fda.gov\/media\/163467\/download?attachment"},{"key":"e_1_3_6_24_1","unstructured":"U.S. Food and Drug Administration. Prescribing Information. BEQVEZTM (fidanacogene elaparvovec-dzkt) injection for intravenous infusion Available from: https:\/\/www.fda.gov\/media\/178140\/download?attachment"},{"key":"e_1_3_6_25_1","volume-title":"Improving representation in clinical trials and research: building research equity for women and underrepresented groups","author":"National Academies of Sciences, Engineering, and Medicine","year":"2022","unstructured":"National Academies of Sciences, Engineering, and Medicine. Improving representation in clinical trials and research: building research equity for women and underrepresented groups. Washington (DC): The National Academies Press; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36137057"},{"key":"e_1_3_6_26_1","unstructured":"World Health Organization. Social Determinants of Health. [cited 2024 Aug 23]. Available from: https:\/\/www.who.int\/health-topics\/social-determinants-of-health#tab=tab_1"},{"key":"e_1_3_6_27_1","unstructured":"U.S. Centers for Disease Control and Prevention. HTC Population Profile. 2024 Mar [cited 2025 Apr 4]. Available from: https:\/\/www.cdc.gov\/hemophilia-community-counts\/php\/data-research\/2024-march-htc-population-profile-patient-characteristics.html"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S325031"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14176"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12810"},{"key":"e_1_3_6_31_1","unstructured":"National Institute for Health and Care Research. Briefing notes for researchers - public involvement in NHS health and social care research. [cited 2024 Aug 7]. Available from: https:\/\/www.nihr.ac.uk\/documents\/briefing-notes-for-researchers-public-involvement-in-nhs-health-and-social-care-research\/27371"},{"key":"e_1_3_6_32_1","unstructured":"National Institutes of Health Community Engagement Alliance. Who we are. Available from: https:\/\/ceal.nih.gov\/who-we-are"},{"key":"e_1_3_6_33_1","unstructured":"Patient-Centered outcomes research Institute. The patient-centered outcomes research Institute strategic plan: generating evidence to achieve more efficient. Effective and equitable health care and improve health for all. [cited 2024 Aug 7]. Available from: https:\/\/www.pcori.org\/about\/about-pcori\/pcori-strategic-plan"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05067"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.2450\/2014.0152-14"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2112233"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2009.184036"},{"key":"e_1_3_6_38_1","unstructured":"Public Involvement Impact Assessment Framework Study Group. The Public Involvement Impact Assessment Framework Guidance Available from: https:\/\/www.piiaf.org.uk\/documents\/piiaf-guidance-jan14.pdf"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/1524839918818830"},{"issue":"99","key":"e_1_3_6_40_1","first-page":"1","article-title":"Community-based participatory research: assessing the evidence","author":"Viswanathan M","year":"2004","unstructured":"Viswanathan M, Ammerman A, Eng E, et al. Community-based participatory research: assessing the evidence. Evid Rep Technol Assess (Summ). 2004 Aug;(99):1\u20138. PMID: 15460504; PMCID: PMC4780908.","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"e_1_3_6_41_1","unstructured":"U.S. Centers for Disease Control and Prevention. About Community Counts Available from: https:\/\/www.cdc.gov\/hemophilia-community-counts\/php\/about\/index.html"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2026.2688867"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2026.2688869"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-017-0179-8"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-052620-103528"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3616-3"},{"key":"e_1_3_6_47_1","unstructured":"Racism: science and tools for the public health Professional. (WA) (DC): APHA Press; 2019. Available from: https:\/\/ajph.aphapublications.org\/doi\/book\/10.2105\/9780875533049"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/heq.2024.0146"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.21972"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.22281"},{"key":"e_1_3_6_51_1","unstructured":"FQHC Associates. What is an FQHC? Available from: https:\/\/www.fqhc.org\/what-is-an-fqhc\/"},{"key":"e_1_3_6_52_1","unstructured":"American Society of Hematology. ASH DEI toolkit for clinical trial sponsors: incorporating DEI principles throughout the clinical trial life cycle. [cited 2025 Apr 15]. Available from: https:\/\/www.hematology.org\/-\/media\/hematology\/files\/dei\/ash-dei-toolkit-for-clinical-trial-sponsors.pdf"},{"key":"e_1_3_6_53_1","unstructured":"Patient-Centered outcomes research Institute. Financial compensation of patients caregivers and patient\/Caregiver organizations engaged in PCORI-Funded research as engaged research partners Available from: https:\/\/nationalhealthcouncil.org\/additional-resources\/patient-compensation-tools"},{"key":"e_1_3_6_54_1","unstructured":"National Health Council. Patient Compensation Tools Available from: https:\/\/nationalhealthcouncil.org\/additional-resources\/patient-compensation-tools\/"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41285-024-00208-3"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13547"},{"key":"e_1_3_6_57_1","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research. Advancing the development of therapeutics through rare disease patient community engagement: virtual public meeting. 2023 [cited 2024 Aug 7]. Available from: www.fda.gov\/media\/179199\/download?attachment"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0936-x"},{"key":"e_1_3_6_59_1","unstructured":"Partners in Bleeding Disorders Education. Live Events and Online Learning Available from: https:\/\/www.partnersprn.org\/"},{"key":"e_1_3_6_60_1","unstructured":"Hemostasis and Thrombosis Research Society. Meetings and Events. [cited 2025 Apr 17]. Available from: https:\/\/www.htrs.org\/meetings-events"},{"key":"e_1_3_6_61_1","unstructured":"Patient-Centered outcomes research Institute. Learning resources for research teams Available from: https:\/\/research-teams.pcori.org\/"},{"key":"e_1_3_6_62_1","unstructured":"Collaborative Institutional Training Initiative. The trusted standard in research ethics compliance and safety training Available from: https:\/\/about.citiprogram.org\/"},{"key":"e_1_3_6_63_1","first-page":"13","volume-title":"Cammeraygal country","author":"McKercher KA","year":"2020","unstructured":"McKercher KA. Part one: foundations for co-design. Beyond sticky notes: doing co-design for real. In: Cammeraygal country. Australia: Inscope Books; 2020. p. 13\u201320."},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1353\/cpr.2019.0064"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732318812773"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.15085"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102264"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14383"},{"key":"e_1_3_6_69_1","unstructured":"Pew Research Center. Internet broadband fact sheet Available from: https:\/\/www.pewresearch.org\/internet\/fact-sheet\/internet-broadband\/"},{"key":"e_1_3_6_70_1","unstructured":"Oregon L. Who we are. [cited 2025 Aug 28]. Available from: https:\/\/www.linkoregon.org\/about\/"},{"key":"e_1_3_6_71_1","unstructured":"U.S. Centers for Disease Control and Prevention. Information on tribes and tribal organizations: tribal public health organizations Available from: https:\/\/www.cdc.gov\/tribal-health\/tribal-organizations\/index.html"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15805"},{"key":"e_1_3_6_73_1","unstructured":"U.S. Food & Drug Administration. Guide to submitting comments to the FDA. [cited 2025 Apr 30]. Available from: https:\/\/www.fda.gov\/patients\/guide-submitting-comments-fda"},{"key":"e_1_3_6_74_1","unstructured":"National Bleeding Disorders Foundation. Washington Days. [cited 2025 Apr 30]. Available from: https:\/\/www.bleeding.org\/events\/washington-days"},{"key":"e_1_3_6_75_1","unstructured":"National Bleeding Disorders Foundation. Voices for Policy Change!. [cited 2025 Apr 30]. Available from: https:\/\/www.bleeding.org\/advocacy\/how-you-can-take-action\/voices-for-policy-change"},{"key":"e_1_3_6_76_1","unstructured":"National Bleeding Disorders Foundation. Pathway to Cures - Blood Disorders venture philanthropy fund. Available from: https:\/\/www.pathwaytocures.org\/"},{"key":"e_1_3_6_77_1","unstructured":"Advanced Research Projects Agency for Health. About ARPA-H Available from: https:\/\/arpa-h.gov\/"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14983"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14403"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2011.09.003"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02915.x"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154443"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.38413"},{"key":"e_1_3_6_84_1","unstructured":"U.S. Food and Drug Administration. Decentralized clinical trials for drugs biological products and devices guidance for industry investigators and other stakeholders Available from: https:\/\/www.fda.gov\/media\/167696\/download"},{"key":"e_1_3_6_85_1","unstructured":"U.S. Food & Drug Administration. Rare pediatric disease designation and priority review voucher programs: information for product sponsors. [cited 2025 Apr 28]. Available from: https:\/\/www.fda.gov\/industry\/medical-products-rare-diseases-and-conditions\/rare-pediatric-disease-designation-and-priority-review-voucher-programs"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2060736"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-020-0143-y"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2021.100769"},{"key":"e_1_3_6_89_1","unstructured":"U.S. Food & Drug Administration. Center for biologics evaluation and research & center for drug evaluation and research real-world evidence: CBER and CDER RWE Program. [cited 2025 Apr 30]. Available from: https:\/\/www.fda.gov\/science-research\/real-world-evidence\/center-biologics-evaluation-and-research-center-drug-evaluation-and-research-real-world-evidence"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2505704"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.12.027"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12468"},{"key":"e_1_3_6_93_1","unstructured":"Library of Congress. H.R.7845 - NIH clinical trial diversity act of. 2022 Available from: https:\/\/www.congress.gov\/bill\/117th-congress\/house-bill\/7845"},{"key":"e_1_3_6_94_1","unstructured":"Library of Congress. S.4486 - health equity and accountability act of. 2022 Available from: https:\/\/www.congress.gov\/bill\/117th-congress\/senate-bill\/4486"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000603"},{"key":"e_1_3_6_96_1","unstructured":"Medical Affairs Professional Society. Patient Centricity Focus Area Working Group. [cited 2025 May 2]. Available from: https:\/\/medicalaffairs.org\/patient-centricity\/"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00310"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2024-328133"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003264"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003265"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13881"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_3_6_103_1","unstructured":"SSC Subcommittee on Von Willebrand Factor. Consensus expert panel opinion to develop a criteria definition of severe Von Willebrand disease. [cited 2024 Aug 22]. Available from: https:\/\/cdn.ymaws.com\/www.isth.org\/resource\/resmgr\/ssc\/ssc_myisth\/SSC_Subcommittee_Project_fin.pdf"},{"key":"e_1_3_6_104_1","unstructured":"Cesta J Morgenthaler C Arapshian A et al. VWD connect Foundation U.S severe Von Willebrand disease patient Registry. World federation of hemophilia 2022 world congress. Montr\u00e9al Canada; 2022 [cited 2024 Aug 2]. Available from: https:\/\/vwdconnect.org\/wp-content\/uploads\/2023\/03\/VWD-Connect-Foundation-U.S.-Severe-VWD-Patient-Registry.pdf"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.15122"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13504"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.2478\/jhp-2024-0020"},{"key":"e_1_3_6_108_1","unstructured":"World Federation of Hemophilia. Report on the annual global survey 2024. 2025 [cited 2026 Mar 11]. Available from: https:\/\/elearning.wfh.org\/resource\/report-on-the-annual-global-survey-2024\/"},{"key":"e_1_3_6_109_1","unstructured":"World Federation of Hemophilia. Annual report 2024. 2025 [cited 2026 Mar 11]. Available from: https:\/\/wfh.org\/about-wfh\/#wfh-annual-report-2024\/1\/"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1353\/cpr.2023.a907963"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-006-9110-1"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.93.5.803"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cyaa010"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1089\/heq.2022.0039"},{"key":"e_1_3_6_115_1","unstructured":"Rau T. Sociocracy - a brief introduction 2021. [cited 2024 Oct 24]. Available from: https:\/\/www.sociocracyforall.org\/wp-content\/uploads\/2022\/06\/Sociocracy-summary-booklet1.pdf"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11266-023-00627-2"},{"key":"e_1_3_6_117_1","unstructured":"Ries E. Minimum viable product: a guide 2009. [cited 2024 Oct 25]. Available from: https:\/\/www.startuplessonslearned.com\/2009\/08\/minimum-viable-product-guide.html"},{"key":"e_1_3_6_118_1","unstructured":"Ries E. The minimum viable product: a primer 2015. [cited 2024 Oct 25]. Available from: https:\/\/medium.com\/galleys\/the-minimum-viable-product-a-primer-3d9a76dd5213"},{"key":"e_1_3_6_119_1","unstructured":"Ries E. Methodology. [cited 2024 Oct 25]. Available from: https:\/\/theleanstartup.com\/principles"},{"key":"e_1_3_6_120_1","first-page":"22","article-title":"The intersections between social determinants of health, health literacy, and health disparities","volume":"269","author":"Schillinger D","year":"2020","unstructured":"Schillinger D. The intersections between social determinants of health, health literacy, and health disparities. Stud Health Technol Inf. 2020;269:22\u201341.","journal-title":"Stud Health Technol Inf"},{"key":"e_1_3_6_121_1","unstructured":"U.S. Department of Education. The health literacy of America\u2019s adults results from the 2003 National assessment of adult literacy 2006 [cited 2024 Oct 27]. Available from: https:\/\/files.eric.ed.gov\/fulltext\/ED493284.pdf"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.4103\/picr.picr_37_25"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-207715"},{"key":"e_1_3_6_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2025.102551"},{"key":"e_1_3_6_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-025-02233-9"},{"key":"e_1_3_6_126_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.1331"},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.1080\/20502877.2025.2483588"},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.70152"},{"key":"e_1_3_6_129_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.6643"},{"key":"e_1_3_6_130_1","unstructured":"U.S. Department of Health and Human Services. Celebrating 100 days of the trump administration. [cited 2025 May 5]. Available from: https:\/\/www.hhs.gov\/hhs-100-days-big-wins-maha\/index.html"},{"key":"e_1_3_6_131_1","unstructured":"Oxford advanced Learner\u2019s dictionary. Inspired - definition Available from: https:\/\/www.oxfordlearnersdictionaries.com\/definition\/english\/inspired?q=inspired"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2688870","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17474086.2026.2688870","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2688870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:59:13Z","timestamp":1786078753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2026.2688870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":130,"journal-issue":{"issue":"sup1","published-print":{"date-parts":[[2026,7,31]]}},"alternative-id":["10.1080\/17474086.2026.2688870"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2026.2688870","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}